Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56,222,082
-
Total 13F shares
-
59,801,004
-
Share change
-
+1,236,145
-
Total reported value
-
$7,995,713,806
-
Put/Call ratio
-
214%
-
Price per share
-
$133.67
-
Number of holders
-
446
-
Value change
-
+$187,488,207
-
Number of buys
-
231
-
Number of sells
-
215
Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2025
As of 30 Sep 2025,
REPLIGEN CORP - COMMON STOCK (RGEN) was held by
446 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
59,801,004 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, UNITED CAPITAL FINANCIAL ADVISORS, LLC, FMR LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Point72 Asset Management, L.P., Holocene Advisors, LP, and Champlain Investment Partners, LLC.
This page lists
446
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.